started · updated
Tadalafil use linked to 22% higher glaucoma risk in large study
A study of 73,854 men aged 40 and older found that daily use of the erectile‑dysfunction drug Tadalafil (Cialis) is associated with a significantly increased risk of glaucoma. Participants who received Tadalafil or another phosphodiesterase‑5 inhibitor for up to five years had a 22 % higher chance of developing any form of glaucoma and a 33 % higher chance of primary open‑angle glaucoma compared with men who did not use these medications.
The researchers, from National Taiwan University Hospital, also reported a one‑third increase in the likelihood of starting glaucoma treatment and a 32 % rise in ocular hypertension, a key risk factor for the disease. The findings suggest that long‑term use of Tadalafil may raise the risk of vision‑loss conditions, prompting clinicians to weigh ocular safety when prescribing the drug for erectile dysfunction or prostate‑related urinary symptoms.
Entities
National Taiwan University Hospital · Primary open‑angle glaucoma · Tadalafil (Cialis)